ArticleAmerican journal of cancer research2026
RPS2 and EEF1B2 are associated with glycolysis-related malignant phenotypes in COAD.
Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lactate metabolism-related reprogramming is closely associated with colon adenocarcinoma (COAD) progression, but related key molecules remain unclear. This study integrated the colorectal cancer single-cell RNA sequencing dataset GSE231559, which served as a single-cell reference and integrated it with bulk RNA-seq data from TCGA-COAD to screen lactate metabolism-related candidate genes. Epithelial cells showed higher lactate metabolism-related transcriptional scores. An overlap-based screening strategy was applied, encompassing three gene sets: epithelial markers associated with lactate metabolism, dysregulated transcripts in the TCGA colon adenocarcinoma cohort, and genes within the co-expression module correlated with the lactate score. This analysis prioritized 14 genes for subsequent investigation. RPS2 and EEF1B2 were selected for further validation. Public database analysis and immunohistochemistry of paired tissues from 50 patients with COAD showed that RPS2 and EEF1B2 were highly expressed in tumor tissues. In HT-29 cells, siRNA-mediated knockdown of RPS2 or EEF1B2 reduced proliferation and migration, increased apoptosis, and decreased HK2, PFK1, PKM2, and LDHA expression, with stronger changes after double knockdown. RPS2 knockdown also increased residual glucose levels and reduced lactate release. Co-immunoprecipitation showed that RPS2 and EEF1B2 were detected in the same protein complex, and EEF1B2 overexpression partially rescued the effects of RPS2 knockdown. These findings suggest that RPS2 and EEF1B2 are associated with glycolysis-related malignant phenotypes in HT-29 cells.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.